Kincell Bio

Kincell Bio, LLC is a leading contract development and manufacturing organization (CDMO) specializing in cell therapy technologies. Kincell provides analytical development, process development, CMC consulting, and early-stage GMP production, with a focus on immune cell therapies, including autologous and allogeneic chimeric antigen receptor (CAR)-T, CAR-NK, and CAR-M programs. The company plans to establish internal mRNA development and additional GMP production capabilities while building trusted partnerships for viral vector and plasmid DNA supply to support all cell engineering processes.